We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01261403
Recruitment Status : Terminated (Enrollment terminated pending additional Phase 1 data)
First Posted : December 16, 2010
Last Update Posted : July 18, 2014
Sponsor:
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : February 2012
  Study Completion Date : September 2013
  Certification or Request for Extension to Delay Results Submission: August 13, 2013